APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Cancer Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastrointestinal Cancer Drugs Market Analysis and Forecast 2026-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchGastrointestinal Cancer Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Cancer Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Cancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Cancer Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Cancer Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gastrointestinal Cancer Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastrointestinal Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastrointestinal Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastrointestinal Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastrointestinal Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastrointestinal Cancer Drugs include Sanofi, Johnson & Johnson Private, Novartis, Roche, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb Company and Celgene Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastrointestinal Cancer Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastrointestinal Cancer Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Gastrointestinal Cancer Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Cancer Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastrointestinal Cancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastrointestinal Cancer Drugs sales, projected growth trends, production technology, application and end-user industry.

Gastrointestinal Cancer Drugs Segment by Company

Sanofi

Johnson & Johnson Private

Novartis

Roche

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Bristol-Myers Squibb Company

Celgene Corporation

Amgen & Amgen Ireland

Gastrointestinal Cancer Drugs Segment by Type

Oncology

Radiology

Others

Gastrointestinal Cancer Drugs Segment by Application

Specialized Cancer Treatment Centers

Clinics

Hospitals

Ambulatory Surgical Centers

Gastrointestinal Cancer Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Cancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Cancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Cancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastrointestinal Cancer Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastrointestinal Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Cancer Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oncology Major Manufacturers Table 3. Radiology Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Specialized Cancer Treatment Centers Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Ambulatory Surgical Centers Major Manufacturers Table 10. Gastrointestinal Cancer Drugs Industry Trends Table 11. Gastrointestinal Cancer Drugs Industry Drivers Table 12. Gastrointestinal Cancer Drugs Industry Opportunities and Challenges Table 13. Gastrointestinal Cancer Drugs Industry Restraints Table 14. Global Gastrointestinal Cancer Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gastrointestinal Cancer Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gastrointestinal Cancer Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Gastrointestinal Cancer Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (g) Table 20. Global Gastrointestinal Cancer Drugs Sales by Region (2021-2026) & (g) Table 21. Global Gastrointestinal Cancer Drugs Sales by Region (2027-2032) & (g) Table 22. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2021-2026) Table 23. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2027-2032) Table 24. Global Gastrointestinal Cancer Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gastrointestinal Cancer Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gastrointestinal Cancer Drugs Sales Price (US$/g) of Manufacturers (2021-2026) Table 29. Global Gastrointestinal Cancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gastrointestinal Cancer Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gastrointestinal Cancer Drugs Manufacturers, Product Type & Application Table 32. Global Gastrointestinal Cancer Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gastrointestinal Cancer Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gastrointestinal Cancer Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Gastrointestinal Cancer Drugs Sales by Type 2021 VS 2025 VS 2032 (g) Table 41. Global Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 42. Global Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 43. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2021-2026) Table 44. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2027-2032) Table 45. Global Gastrointestinal Cancer Drugs Price by Type (2021-2026) & (US$/g) Table 46. Global Gastrointestinal Cancer Drugs Price by Type (2027-2032) & (US$/g) Table 47. Global Gastrointestinal Cancer Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Gastrointestinal Cancer Drugs Sales by Application 2021 VS 2025 VS 2032 (g) Table 53. Global Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 54. Global Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 55. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2021-2026) Table 56. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2027-2032) Table 57. Global Gastrointestinal Cancer Drugs Price by Application (2021-2026) & (US$/g) Table 58. Global Gastrointestinal Cancer Drugs Price by Application (2027-2032) & (US$/g) Table 59. Sanofi Company Information Table 60. Sanofi Business Overview Table 61. Sanofi Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 62. Sanofi Gastrointestinal Cancer Drugs Product Portfolio Table 63. Sanofi Recent Development Table 64. Johnson & Johnson Private Company Information Table 65. Johnson & Johnson Private Business Overview Table 66. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Portfolio Table 68. Johnson & Johnson Private Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 72. Novartis Gastrointestinal Cancer Drugs Product Portfolio Table 73. Novartis Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Roche Gastrointestinal Cancer Drugs Product Portfolio Table 78. Roche Recent Development Table 79. Eli Lilly and Company Company Information Table 80. Eli Lilly and Company Business Overview Table 81. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 82. Eli Lilly and Company Gastrointestinal Cancer Drugs Product Portfolio Table 83. Eli Lilly and Company Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 87. Pfizer Gastrointestinal Cancer Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Gastrointestinal Cancer Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Bristol-Myers Squibb Company Company Information Table 95. Bristol-Myers Squibb Company Business Overview Table 96. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 97. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Portfolio Table 98. Bristol-Myers Squibb Company Recent Development Table 99. Celgene Corporation Company Information Table 100. Celgene Corporation Business Overview Table 101. Celgene Corporation Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 102. Celgene Corporation Gastrointestinal Cancer Drugs Product Portfolio Table 103. Celgene Corporation Recent Development Table 104. Amgen & Amgen Ireland Company Information Table 105. Amgen & Amgen Ireland Business Overview Table 106. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 107. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Portfolio Table 108. Amgen & Amgen Ireland Recent Development Table 109. North America Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 112. North America Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 113. North America Gastrointestinal Cancer Drugs Sales Price by Type (2021-2026) & (US$/g) Table 114. North America Gastrointestinal Cancer Drugs Sales Price by Type (2027-2032) & (US$/g) Table 115. North America Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 118. North America Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 119. North America Gastrointestinal Cancer Drugs Sales Price by Application (2021-2026) & (US$/g) Table 120. North America Gastrointestinal Cancer Drugs Sales Price by Application (2027-2032) & (US$/g) Table 121. North America Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (g) Table 125. North America Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 126. North America Gastrointestinal Cancer Drugs Sales by Country (2027-2032) & (g) Table 127. North America Gastrointestinal Cancer Drugs Sales Price by Country (2021-2026) & (US$/g) Table 128. North America Gastrointestinal Cancer Drugs Sales Price by Country (2027-2032) & (US$/g) Table 129. United States Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 130. Canada Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 131. Mexico Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 132. Europe Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 135. Europe Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 136. Europe Gastrointestinal Cancer Drugs Sales Price by Type (2021-2026) & (US$/g) Table 137. Europe Gastrointestinal Cancer Drugs Sales Price by Type (2027-2032) & (US$/g) Table 138. Europe Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 141. Europe Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 142. Europe Gastrointestinal Cancer Drugs Sales Price by Application (2021-2026) & (US$/g) Table 143. Europe Gastrointestinal Cancer Drugs Sales Price by Application (2027-2032) & (US$/g) Table 144. Europe Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (g) Table 148. Europe Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 149. Europe Gastrointestinal Cancer Drugs Sales by Country (2027-2032) & (g) Table 150. Europe Gastrointestinal Cancer Drugs Sales Price by Country (2021-2026) & (US$/g) Table 151. Europe Gastrointestinal Cancer Drugs Sales Price by Country (2027-2032) & (US$/g) Table 152. Germany Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 153. France Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 154. U.K. Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 155. Italy Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 156. Russia Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 157. Spain Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 159. Switzerland Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 160. Sweden Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 161. Poland Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 162. China Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. China Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. China Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 165. China Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 166. China Gastrointestinal Cancer Drugs Sales Price by Type (2021-2026) & (US$/g) Table 167. China Gastrointestinal Cancer Drugs Sales Price by Type (2027-2032) & (US$/g) Table 168. China Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 169. China Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 170. China Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 171. China Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 172. China Gastrointestinal Cancer Drugs Sales Price by Application (2021-2026) & (US$/g) Table 173. China Gastrointestinal Cancer Drugs Sales Price by Application (2027-2032) & (US$/g) Table 174. Asia Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 177. Asia Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 178. Asia Gastrointestinal Cancer Drugs Sales Price by Type (2021-2026) & (US$/g) Table 179. Asia Gastrointestinal Cancer Drugs Sales Price by Type (2027-2032) & (US$/g) Table 180. Asia Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 183. Asia Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 184. Asia Gastrointestinal Cancer Drugs Sales Price by Application (2021-2026) & (US$/g) Table 185. Asia Gastrointestinal Cancer Drugs Sales Price by Application (2027-2032) & (US$/g) Table 186. Asia Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (g) Table 190. Asia Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 191. Asia Gastrointestinal Cancer Drugs Sales by Country (2027-2032) & (g) Table 192. Asia Gastrointestinal Cancer Drugs Sales Price by Country (2021-2026) & (US$/g) Table 193. Asia Gastrointestinal Cancer Drugs Sales Price by Country (2027-2032) & (US$/g) Table 194. Japan Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 195. South Korea Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 196. India Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 197. Australia Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 198. Taiwan Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Gastrointestinal Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 203. SAMEA Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 204. SAMEA Gastrointestinal Cancer Drugs Sales Price by Type (2021-2026) & (US$/g) Table 205. SAMEA Gastrointestinal Cancer Drugs Sales Price by Type (2027-2032) & (US$/g) Table 206. SAMEA Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Gastrointestinal Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 209. SAMEA Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 210. SAMEA Gastrointestinal Cancer Drugs Sales Price by Application (2021-2026) & (US$/g) Table 211. SAMEA Gastrointestinal Cancer Drugs Sales Price by Application (2027-2032) & (US$/g) Table 212. SAMEA Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (g) Table 216. SAMEA Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 217. SAMEA Gastrointestinal Cancer Drugs Sales by Country (2027-2032) & (g) Table 218. SAMEA Gastrointestinal Cancer Drugs Sales Price by Country (2021-2026) & (US$/g) Table 219. SAMEA Gastrointestinal Cancer Drugs Sales Price by Country (2027-2032) & (US$/g) Table 220. Brazil Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 221. Argentina Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 222. Chile Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 223. Colombia Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 224. Peru Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 226. Israel Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 227. UAE Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 228. Turkey Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 229. Iran Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 230. Egypt Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Gastrointestinal Cancer Drugs Distributors List Table 234. Gastrointestinal Cancer Drugs Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Gastrointestinal Cancer Drugs Image Figure 2. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Cancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oncology Image Figure 5. Radiology Image Figure 6. Others Image Figure 7. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gastrointestinal Cancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Specialized Cancer Treatment Centers Image Figure 10. Clinics Image Figure 11. Hospitals Image Figure 12. Ambulatory Surgical Centers Image Figure 13. Global Gastrointestinal Cancer Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastrointestinal Cancer Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Gastrointestinal Cancer Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Gastrointestinal Cancer Drugs Sales (2021-2032) & (g) Figure 19. Global Gastrointestinal Cancer Drugs Sales by Region: 2021 VS 2025 VS 2032 (g) Figure 20. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gastrointestinal Cancer Drugs Sales YoY (2021-2032) & (g) Figure 22. Europe Gastrointestinal Cancer Drugs Sales YoY (2021-2032) & (g) Figure 23. China Gastrointestinal Cancer Drugs Sales YoY (2021-2032) & (g) Figure 24. Asia (Excluding China) Gastrointestinal Cancer Drugs Sales YoY (2021-2032) & (g) Figure 25. South America, Middle East and Africa Gastrointestinal Cancer Drugs Sales YoY (2021-2032) & (g) Figure 26. Global Gastrointestinal Cancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gastrointestinal Cancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gastrointestinal Cancer Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Gastrointestinal Cancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (g) Figure 33. Global Gastrointestinal Cancer Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Gastrointestinal Cancer Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Gastrointestinal Cancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (g) Figure 39. Global Gastrointestinal Cancer Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2032) Figure 42. North America Gastrointestinal Cancer Drugs Sales Share by Type (2021-2032) Figure 43. North America Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2032) Figure 44. North America Gastrointestinal Cancer Drugs Sales Share by Application (2021-2032) Figure 45. North America Gastrointestinal Cancer Drugs Revenue Share by Country (2021-2032) Figure 46. North America Gastrointestinal Cancer Drugs Sales Share by Country (2021-2032) Figure 47. Europe Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Gastrointestinal Cancer Drugs Sales Share by Type (2021-2032) Figure 49. Europe Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Gastrointestinal Cancer Drugs Sales Share by Application (2021-2032) Figure 51. Europe Gastrointestinal Cancer Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Gastrointestinal Cancer Drugs Sales Share by Country (2021-2032) Figure 53. China Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2032) Figure 54. China Gastrointestinal Cancer Drugs Sales Share by Type (2021-2032) Figure 55. China Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2032) Figure 56. China Gastrointestinal Cancer Drugs Sales Share by Application (2021-2032) Figure 57. Asia Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Gastrointestinal Cancer Drugs Sales Share by Type (2021-2032) Figure 59. Asia Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Gastrointestinal Cancer Drugs Sales Share by Application (2021-2032) Figure 61. Asia Gastrointestinal Cancer Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Gastrointestinal Cancer Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Gastrointestinal Cancer Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Gastrointestinal Cancer Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Gastrointestinal Cancer Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Gastrointestinal Cancer Drugs Sales Share by Country (2021-2032) Figure 69. Gastrointestinal Cancer Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gastrointestinal Cancer Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Oncology
  • Radiology
  • Others
Applications
  • Specialized Cancer Treatment Centers
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Sanofi
  • Johnson & Johnson Private
  • Novartis
  • Roche
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Amgen & Amgen Ireland

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastrointestinal Cancer Drugs Market by Type
  3. 1.2.1 Global Gastrointestinal Cancer Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oncology
  5. 1.2.3 Radiology
  6. 1.2.4 Others
  7. 1.3 Gastrointestinal Cancer Drugs Market by Application
  8. 1.3.1 Global Gastrointestinal Cancer Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Specialized Cancer Treatment Centers
  10. 1.3.3 Clinics
  11. 1.3.4 Hospitals
  12. 1.3.5 Ambulatory Surgical Centers
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gastrointestinal Cancer Drugs Market Dynamics
  1. 2.1 Gastrointestinal Cancer Drugs Industry Trends
  2. 2.2 Gastrointestinal Cancer Drugs Industry Drivers
  3. 2.3 Gastrointestinal Cancer Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Cancer Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastrointestinal Cancer Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastrointestinal Cancer Drugs Revenue by Region
  3. 3.2.1 Global Gastrointestinal Cancer Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastrointestinal Cancer Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastrointestinal Cancer Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastrointestinal Cancer Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastrointestinal Cancer Drugs Sales by Region
  9. 3.4.1 Global Gastrointestinal Cancer Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastrointestinal Cancer Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Gastrointestinal Cancer Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastrointestinal Cancer Drugs Revenue by Manufacturers
  2. 4.1.1 Global Gastrointestinal Cancer Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastrointestinal Cancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastrointestinal Cancer Drugs Sales by Manufacturers
  6. 4.2.1 Global Gastrointestinal Cancer Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastrointestinal Cancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastrointestinal Cancer Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastrointestinal Cancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastrointestinal Cancer Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastrointestinal Cancer Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Gastrointestinal Cancer Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastrointestinal Cancer Drugs Market CR5 and HHI
  16. 4.8.2 2025 Gastrointestinal Cancer Drugs Tier 1, Tier 2, and Tier 3
5 Gastrointestinal Cancer Drugs Market by Type
  1. 5.1 Global Gastrointestinal Cancer Drugs Revenue by Type
  2. 5.1.1 Global Gastrointestinal Cancer Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastrointestinal Cancer Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastrointestinal Cancer Drugs Sales by Type
  6. 5.2.1 Global Gastrointestinal Cancer Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal Cancer Drugs Sales by Type (2021-2032) & (g)
  8. 5.2.3 Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastrointestinal Cancer Drugs Price by Type
6 Gastrointestinal Cancer Drugs Market by Application
  1. 6.1 Global Gastrointestinal Cancer Drugs Revenue by Application
  2. 6.1.1 Global Gastrointestinal Cancer Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastrointestinal Cancer Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastrointestinal Cancer Drugs Sales by Application
  6. 6.2.1 Global Gastrointestinal Cancer Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastrointestinal Cancer Drugs Sales by Application (2021-2032) & (g)
  8. 6.2.3 Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastrointestinal Cancer Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Gastrointestinal Cancer Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson Private
  8. 7.2.1 Johnson & Johnson Private Company Information
  9. 7.2.2 Johnson & Johnson Private Business Overview
  10. 7.2.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Portfolio
  12. 7.2.5 Johnson & Johnson Private Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Gastrointestinal Cancer Drugs Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Gastrointestinal Cancer Drugs Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Eli Lilly and Company
  26. 7.5.1 Eli Lilly and Company Company Information
  27. 7.5.2 Eli Lilly and Company Business Overview
  28. 7.5.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Product Portfolio
  30. 7.5.5 Eli Lilly and Company Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Gastrointestinal Cancer Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Bristol-Myers Squibb Company
  44. 7.8.1 Bristol-Myers Squibb Company Company Information
  45. 7.8.2 Bristol-Myers Squibb Company Business Overview
  46. 7.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Portfolio
  48. 7.8.5 Bristol-Myers Squibb Company Recent Developments
  49. 7.9 Celgene Corporation
  50. 7.9.1 Celgene Corporation Company Information
  51. 7.9.2 Celgene Corporation Business Overview
  52. 7.9.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Celgene Corporation Gastrointestinal Cancer Drugs Product Portfolio
  54. 7.9.5 Celgene Corporation Recent Developments
  55. 7.10 Amgen & Amgen Ireland
  56. 7.10.1 Amgen & Amgen Ireland Company Information
  57. 7.10.2 Amgen & Amgen Ireland Business Overview
  58. 7.10.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Portfolio
  60. 7.10.5 Amgen & Amgen Ireland Recent Developments
8 North America
  1. 8.1 North America Gastrointestinal Cancer Drugs Market Size by Type
  2. 8.1.1 North America Gastrointestinal Cancer Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastrointestinal Cancer Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Gastrointestinal Cancer Drugs Price by Type (2021-2032)
  5. 8.2 North America Gastrointestinal Cancer Drugs Market Size by Application
  6. 8.2.1 North America Gastrointestinal Cancer Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastrointestinal Cancer Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Gastrointestinal Cancer Drugs Price by Application (2021-2032)
  9. 8.3 North America Gastrointestinal Cancer Drugs Market Size by Country
  10. 8.3.1 North America Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastrointestinal Cancer Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gastrointestinal Cancer Drugs Market Size by Type
  2. 9.1.1 Europe Gastrointestinal Cancer Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastrointestinal Cancer Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastrointestinal Cancer Drugs Price by Type (2021-2032)
  5. 9.2 Europe Gastrointestinal Cancer Drugs Market Size by Application
  6. 9.2.1 Europe Gastrointestinal Cancer Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastrointestinal Cancer Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastrointestinal Cancer Drugs Price by Application (2021-2032)
  9. 9.3 Europe Gastrointestinal Cancer Drugs Market Size by Country
  10. 9.3.1 Europe Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastrointestinal Cancer Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gastrointestinal Cancer Drugs Market Size by Type
  2. 10.1.1 China Gastrointestinal Cancer Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Gastrointestinal Cancer Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Gastrointestinal Cancer Drugs Price by Type (2021-2032)
  5. 10.2 China Gastrointestinal Cancer Drugs Market Size by Application
  6. 10.2.1 China Gastrointestinal Cancer Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Gastrointestinal Cancer Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Gastrointestinal Cancer Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastrointestinal Cancer Drugs Market Size by Type
  2. 11.1.1 Asia Gastrointestinal Cancer Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastrointestinal Cancer Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastrointestinal Cancer Drugs Price by Type (2021-2032)
  5. 11.2 Asia Gastrointestinal Cancer Drugs Market Size by Application
  6. 11.2.1 Asia Gastrointestinal Cancer Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastrointestinal Cancer Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastrointestinal Cancer Drugs Price by Application (2021-2032)
  9. 11.3 Asia Gastrointestinal Cancer Drugs Market Size by Country
  10. 11.3.1 Asia Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastrointestinal Cancer Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastrointestinal Cancer Drugs Market Size by Type
  2. 12.1.1 SAMEA Gastrointestinal Cancer Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastrointestinal Cancer Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastrointestinal Cancer Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Gastrointestinal Cancer Drugs Market Size by Application
  6. 12.2.1 SAMEA Gastrointestinal Cancer Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastrointestinal Cancer Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastrointestinal Cancer Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Gastrointestinal Cancer Drugs Market Size by Country
  10. 12.3.1 SAMEA Gastrointestinal Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastrointestinal Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastrointestinal Cancer Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastrointestinal Cancer Drugs Value Chain Analysis
  2. 13.1.1 Gastrointestinal Cancer Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastrointestinal Cancer Drugs Production Mode & Process
  6. 13.2 Gastrointestinal Cancer Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastrointestinal Cancer Drugs Distributors
  9. 13.2.3 Gastrointestinal Cancer Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst